NL-OMON23341已完成不适用
Bortezomib (Velcade®): A feasibility and phase II study in childhood relapsed acute lymphoblastic leukemia.
Erasmus MC, Rotterdam, Netherlands0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Age between 6 months and 19 years;
- •2. Patients with a second or subsequent relapsed ALL;
排除标准
- •1. Relapse not involving bone marrow;
- •2. Symptomatic CNS leukemia;
研究者
相似试验
已完成
2 期
Bortezomib (Velcade®): A feasibility and phase II study in childhood relapsed acute lymphoblastic leukemiaNL-OMON35519Erasmus MC, Universitair Medisch Centrum Rotterdam4
进行中（未招募）
不适用
Bortezomib (Velcade®): a feasibility and phase II study in childhood relapsed acute lymphoblastic leukemia - Bortezomib in relapsed Aacute lymphoblastic leukemiaMedDRA version: 12.0Level: LLTClassification code 10063625Term: Acute lymphoblastic leukemia recurrentEUCTR2009-014037-25-NLErasmus MC24
进行中（未招募）
1 期
Bortezomib (Velcade®): a feasibility and phase II study in childhood relapsed acute lymphoblastic leukemia - Bortezomib in relapsed Aacute lymphoblastic leukemiaMedDRA version: 14.1Level: LLTClassification code 10063625Term: Acute lymphoblastic leukemia recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2009-014037-25-DEErasmus MC24
进行中（未招募）
1 期
Bortezomib trial for the treatment of childhood relapsed acute lymphoblastic leukemiaacute lymphoblastic leukemiaMedDRA version: 14.1Level: LLTClassification code 10063625Term: Acute lymphoblastic leukemia recurrentSystem Organ Class: 100000004864EUCTR2009-014037-25-DKErasmus MC24
进行中（未招募）
1 期
Bortezomib (Velcade®): a feasibility and phase II study in childhood relapsed acute lymphoblastic leukemiaAcute lymphoblastic leukemia (ALL)MedDRA version: 14.1Level: LLTClassification code 10063625Term: Acute lymphoblastic leukemia recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2009-014037-25-BEniversity Hospital Ghent29